NCT01110291: induction of CYP3A activity and lowered exposure to docetaxel in patients with primary breast cancer

Johanna Hilli, Liisa Sailas, Sirkku Jyrkkiö, Seppo Pyrhönen, Kari Laine

Open source

DOI
10.1007/s00280-010-1426-6
Published
2010-08-27
Container
Cancer Chemotherapy and Pharmacology
Publisher
Springer Science and Business Media LLC
Open access
unknown

Credibility signals

uncertain Score 64/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.1007/s00280-010-1426-6,
  title = {NCT01110291: induction of CYP3A activity and lowered exposure to docetaxel in patients with primary breast cancer},
  author = {Johanna Hilli and Liisa Sailas and Sirkku Jyrkkiö and Seppo Pyrhönen and Kari Laine},
  year = {2010},
  journal = {Cancer Chemotherapy and Pharmacology},
  doi = {10.1007/s00280-010-1426-6},
  url = {https://doi.org/10.1007/s00280-010-1426-6}
}

RIS

TY  - JOUR
TI  - NCT01110291: induction of CYP3A activity and lowered exposure to docetaxel in patients with primary breast cancer
AU  - Johanna Hilli
AU  - Liisa Sailas
AU  - Sirkku Jyrkkiö
AU  - Seppo Pyrhönen
AU  - Kari Laine
PY  - 2010
JO  - Cancer Chemotherapy and Pharmacology
DO  - 10.1007/s00280-010-1426-6
UR  - https://doi.org/10.1007/s00280-010-1426-6
ER  - 

APA

Hilli, J., Sailas, L., Jyrkkiö, S., Pyrhönen, S., & Laine, K. (2010). NCT01110291: induction of CYP3A activity and lowered exposure to docetaxel in patients with primary breast cancer. Cancer Chemotherapy and Pharmacology. https://doi.org/10.1007/s00280-010-1426-6

Source records